Goldman Sachs
-
Corporate borrowers are taking advantage of rising political worry among investors by issuing short dated floating rate notes in euros which stand a good chance of bearing negative yields, write Michael Turner, Ross Lancaster and Jon Hay. -
-
-
After weeks wracked by political turbulence, the euro market has finally been able to enjoy a clean run with supportive conditions.
-
German card payments firm Concardis this week increased the term loan backing Advent International and Bain Capital’s buyout of the firm to €300m, reducing price guidance in the process, in a market still waiting on larger buyouts such as Cerba Healthcare to be syndicated.
-
The European high yield bond market has rebooted after a February in which US firms dominated sales, with so many local issuers now coming forward that high yield bankers have started worrying that March could be overcrowded if the entire deal pipeline materialises.
-
UBS’s co-head of global capital markets for Australasia Dane FitzGibbon is leaving the bank, according to sources close to the move.
-
BioPharma Credit, the closed end investment company focused on life sciences, has announced the largest UK IPO of the year so far.
-
The European Investment Bank launched a €5bn seven year benchmark on Wednesday, pulling in what two SSA syndicate bankers said is one of the largest books ever for an Earn transaction.
-
Goldman Sachs has given additional client coverage responsibilities to its Australia and New Zealand co-heads of investment banking services (IBS) Joe Fayyad and Zac Fletcher, according to two memos on Tuesday seen by GlobalCapital Asia.
-
The European Investment Bank is set to tackle the seven year part of the euro curve on Wednesday, an area that has had no issuance from SSAs since early February.
-
UniCredit, the largest bank in Italy, has formally finished its €13bn rights issue after selling the unexercised rights on the market for €15m.
